Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Label-free Raman spectroscopy provides early determination and precise localization of breast cancer-colonized bone alterations.

Zhang C, Winnard PT Jr, Dasari S, Kominsky SL, Doucet M, Jayaraman S, Raman V, Barman I.

Chem Sci. 2017 Nov 15;9(3):743-753. doi: 10.1039/c7sc02905e. eCollection 2018 Jan 21.

2.

Role of DDX3 in the pathogenesis of inflammatory bowel disease.

Tantravedi S, Vesuna F, Winnard PT Jr, Van Voss MRH, Van Diest PJ, Raman V.

Oncotarget. 2017 Dec 15;8(70):115280-115289. doi: 10.18632/oncotarget.23323. eCollection 2017 Dec 29.

3.

Delayed Progression of Lung Metastases Following Delivery of a Prodrug-activating Enzyme.

Dore-Savard L, Chen Z, Winnard PT Jr, Krishnamachary B, Raman V, Black ME, Bhujwalla ZM.

Anticancer Res. 2017 May;37(5):2195-2200.

PMID:
28476782
4.

Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes.

Winnard PT Jr, Zhang C, Vesuna F, Kang JW, Garry J, Dasari RR, Barman I, Raman V.

Oncotarget. 2017 Mar 21;8(12):20266-20287. doi: 10.18632/oncotarget.14865.

5.

Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.

Winnard PT Jr, Bharti SK, Penet MF, Marik R, Mironchik Y, Wildes F, Maitra A, Bhujwalla ZM.

Cancer Res. 2016 Mar 15;76(6):1441-50. doi: 10.1158/0008-5472.CAN-15-1740. Epub 2015 Dec 30.

6.

NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.

Xie M, Vesuna F, Botlagunta M, Bol GM, Irving A, Bergman Y, Hosmane RS, Kato Y, Winnard PT Jr, Raman V.

Oncotarget. 2015 Oct 6;6(30):29901-13. doi: 10.18632/oncotarget.4898.

7.

Direct facile screening of recombinant DNA vector constructs.

Winnard PT Jr, Challa R, Bhujwalla ZM, Raman V.

Anal Biochem. 2014 Apr 1;450:1-3. doi: 10.1016/j.ab.2013.12.034. Epub 2014 Jan 3.

8.

Mass spectrometric imaging of red fluorescent protein in breast tumor xenografts.

Chughtai K, Jiang L, Post H, Winnard PT Jr, Greenwood TR, Raman V, Bhujwalla ZM, Heeren RM, Glunde K.

J Am Soc Mass Spectrom. 2013 May;24(5):711-7. doi: 10.1007/s13361-012-0503-y. Epub 2012 Nov 27.

9.

Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models.

Jiang L, Greenwood TR, Artemov D, Raman V, Winnard PT Jr, Heeren RM, Bhujwalla ZM, Glunde K.

Neoplasia. 2012 Aug;14(8):732-41.

10.

Combined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model.

Jiang L, Greenwood TR, van Hove ER, Chughtai K, Raman V, Winnard PT Jr, Heeren RM, Artemov D, Glunde K.

NMR Biomed. 2013 Mar;26(3):285-98. doi: 10.1002/nbm.2846. Epub 2012 Sep 4.

11.

PSMA-targeted theranostic nanoplex for prostate cancer therapy.

Chen Z, Penet MF, Nimmagadda S, Li C, Banerjee SR, Winnard PT Jr, Artemov D, Glunde K, Pomper MG, Bhujwalla ZM.

ACS Nano. 2012 Sep 25;6(9):7752-7762. doi: 10.1021/nn301725w. Epub 2012 Aug 9.

12.

Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage.

Penet MF, Chen Z, Li C, Winnard PT Jr, Bhujwalla ZM.

Drug Deliv Transl Res. 2012 Feb 1;2(1):22-30. doi: 10.1007/s13346-011-0052-0.

13.

Understanding cancer-induced cachexia: imaging the flame and its fuel.

Penet MF, Winnard PT Jr, Jacobs MA, Bhujwalla ZM.

Curr Opin Support Palliat Care. 2011 Dec;5(4):327-33. doi: 10.1097/SPC.0b013e32834c49ba. Review.

14.

HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.

Zhang H, Wong CC, Wei H, Gilkes DM, Korangath P, Chaturvedi P, Schito L, Chen J, Krishnamachary B, Winnard PT Jr, Raman V, Zhen L, Mitzner WA, Sukumar S, Semenza GL.

Oncogene. 2012 Apr 5;31(14):1757-70. doi: 10.1038/onc.2011.365. Epub 2011 Aug 22.

15.

Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells.

Botlagunta M, Krishnamachary B, Vesuna F, Winnard PT Jr, Bol GM, Patel AH, Raman V.

PLoS One. 2011 Mar 23;6(3):e17563. doi: 10.1371/journal.pone.0017563.

16.

Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy.

Li C, Penet MF, Wildes F, Takagi T, Chen Z, Winnard PT, Artemov D, Bhujwalla ZM.

ACS Nano. 2010 Nov 23;4(11):6707-16. doi: 10.1021/nn102187v. Epub 2010 Oct 19.

17.

Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells.

Shah T, Wildes F, Penet MF, Winnard PT Jr, Glunde K, Artemov D, Ackerstaff E, Gimi B, Kakkad S, Raman V, Bhujwalla ZM.

NMR Biomed. 2010 Jul;23(6):633-42. doi: 10.1002/nbm.1510.

18.

Neoplastic transformation of breast epithelial cells by genotoxic stress.

Botlagunta M, Winnard PT Jr, Raman V.

BMC Cancer. 2010 Jun 30;10:343. doi: 10.1186/1471-2407-10-343.

19.

Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung.

Satoh H, Moriguchi T, Taguchi K, Takai J, Maher JM, Suzuki T, Winnard PT Jr, Raman V, Ebina M, Nukiwa T, Yamamoto M.

Carcinogenesis. 2010 Oct;31(10):1833-43. doi: 10.1093/carcin/bgq105. Epub 2010 May 31.

PMID:
20513672
20.
21.

A PET rat model for assessing the effectiveness of new chemotherapies.

Winnard PT Jr, Sukumar S.

Cancer Biol Ther. 2008 Apr;7(4):538-9. No abstract available.

PMID:
18627116
22.

Molecular imaging of metastatic potential.

Winnard PT Jr, Pathak AP, Dhara S, Cho SY, Raman V, Pomper MG.

J Nucl Med. 2008 Jun;49 Suppl 2:96S-112S. doi: 10.2967/jnumed.107.045948. Review.

23.

Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model.

Winnard PT Jr, Botlagunta M, Kluth JB, Mukadam S, Krishnamachary B, Vesuna F, Raman V.

Cancer Gene Ther. 2008 Oct;15(10):645-54. doi: 10.1038/cgt.2008.39. Epub 2008 Jun 13.

24.

Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.

Glunde K, Shah T, Winnard PT Jr, Raman V, Takagi T, Vesuna F, Artemov D, Bhujwalla ZM.

Cancer Res. 2008 Jan 1;68(1):172-80. doi: 10.1158/0008-5472.CAN-07-2678.

25.

Development of novel chimeric transmembrane proteins for multimodality imaging of cancer cells.

Winnard PT Jr, Kluth JB, Kato Y, Artemov D, Raman V.

Cancer Biol Ther. 2007 Dec;6(12):1889-99. Epub 2007 Sep 1.

PMID:
18059163
26.

Developing MR reporter genes: promises and pitfalls.

Gilad AA, Winnard PT Jr, van Zijl PC, Bulte JW.

NMR Biomed. 2007 May;20(3):275-90. Review.

PMID:
17451181
27.

Artificial reporter gene providing MRI contrast based on proton exchange.

Gilad AA, McMahon MT, Walczak P, Winnard PT Jr, Raman V, van Laarhoven HW, Skoglund CM, Bulte JW, van Zijl PC.

Nat Biotechnol. 2007 Feb;25(2):217-9. Epub 2007 Jan 28.

PMID:
17259977
28.

Multimodal image-guided enzyme/prodrug cancer therapy.

Li C, Winnard PT Jr, Takagi T, Artemov D, Bhujwalla ZM.

J Am Chem Soc. 2006 Nov 29;128(47):15072-3.

PMID:
17117842
29.

Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model.

Raman V, Artemov D, Pathak AP, Winnard PT Jr, McNutt S, Yudina A, Bogdanov A Jr, Bhujwalla ZM.

Cancer Res. 2006 Oct 15;66(20):9929-36.

30.
31.

HOXA5 regulates hMLH1 expression in breast cancer cells.

Duriseti S, Winnard PT Jr, Mironchik Y, Vesuna F, Raman A, Raman V.

Neoplasia. 2006 Apr;8(4):250-8.

32.

Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

Mironchik Y, Winnard PT Jr, Vesuna F, Kato Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, Van Diest P, Burger H, Glackin C, Raman V.

Cancer Res. 2005 Dec 1;65(23):10801-9.

33.

The molecular weight and oligomerization of rabbit thrombomodulin as assessed by sedimentation equilibrium.

Winnard PT, Esmon CT, Laue TM.

Arch Biochem Biophys. 1989 Feb 15;269(1):339-44.

PMID:
2537060

Supplemental Content

Loading ...
Support Center